Files in this item
Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents
Item metadata
dc.contributor.author | Ashok, Penta | |
dc.contributor.author | Chander, Subhash | |
dc.contributor.author | Smith, Terry K. | |
dc.contributor.author | Sankaranarayanan, Murugesan | |
dc.date.accessioned | 2019-03-08T00:38:05Z | |
dc.date.available | 2019-03-08T00:38:05Z | |
dc.date.issued | 2018-04-25 | |
dc.identifier | 252727199 | |
dc.identifier | 06db689e-82e5-4886-96cb-6b54281762eb | |
dc.identifier | 85043586210 | |
dc.identifier | 000430891400037 | |
dc.identifier.citation | Ashok , P , Chander , S , Smith , T K & Sankaranarayanan , M 2018 , ' Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents ' , European Journal Of Medicinal Chemistry , vol. 150 , pp. 559-566 . https://doi.org/10.1016/j.ejmech.2018.03.022 | en |
dc.identifier.issn | 0223-5234 | |
dc.identifier.other | RIS: urn:B46948A04E5094ADD0BAF35C1C5146CA | |
dc.identifier.uri | https://hdl.handle.net/10023/17244 | |
dc.description | One of the authors, Ashok Penta, acknowledges Council of Scientific and Industrial Research, New Delhi, India for financial support in the form of Senior Research Fellowship. Other authors gratefully acknowledge BITS-Pilani for providing the necessary facilities to do this work. This work was carried out under a grant from Science and Engineering Research Board of Department of Science and Technology, New Delhi. (Ref. No: SR/FT/LS-58/2011). This work was also partially supported by TKS's Welcome Trust project grant 093228 and the European Community's Seventh Framework Program under grant agreement No.602773 (Project KINDRED). | en |
dc.description.abstract | Molecular hybridization is a ligand based drug design approach is well known recent medicinal chemistry to design anti-parasitic agents. In the present study, we have designed a series of (1-phenyl-9H-pyrido [3,4-b]indol-3-yl) (4-phenylpiperazin-1-yl)methanone derivatives using molecular hybridization approach. Designed analogues were evaluated for cytotoxicity and inhibition activity against Leishmania infantum and Leishmania donovani. Among these reported analogues 7b , 7d , 7e , 7f and 7m displayed potent inhibition of both L. infantum and L. donovani. Compounds 7i and 7k exhibited selective potent inhibition of L. donovani. Especially, compounds 7e and 7k showed most potent anti-leishmanial activity against L. infantum and L. donovani respectively. Anti-leishmanial activity of these compounds is comparable with standard drugs miltefosine and pentamidine. SAR studies revealed that, electron donating group substitution on phenyl ring recommended for potent anti-leishmanial activity. | |
dc.format.extent | 8 | |
dc.format.extent | 650684 | |
dc.language.iso | eng | |
dc.relation.ispartof | European Journal Of Medicinal Chemistry | en |
dc.subject | Molecular hybridization | en |
dc.subject | β-carboline | en |
dc.subject | Anti-leishmanial activity | en |
dc.subject | RM Therapeutics. Pharmacology | en |
dc.subject | QD Chemistry | en |
dc.subject | NDAS | en |
dc.subject.lcc | RM | en |
dc.subject.lcc | QD | en |
dc.title | Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents | en |
dc.type | Journal article | en |
dc.contributor.sponsor | The Wellcome Trust | en |
dc.contributor.sponsor | European Commission | en |
dc.contributor.institution | University of St Andrews. School of Biology | en |
dc.contributor.institution | University of St Andrews. Biomedical Sciences Research Complex | en |
dc.identifier.doi | 10.1016/j.ejmech.2018.03.022 | |
dc.description.status | Peer reviewed | en |
dc.date.embargoedUntil | 2019-03-08 | |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0223523418302654#appsec1 | en |
dc.identifier.grantnumber | 093228/Z/10/Z | en |
dc.identifier.grantnumber | 602773 | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.